BIOLARGO, INC. (BLGO)

Sorry, no known transcripts

Recent filings

BioLargo to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021 - Sept. 8, 2021

BioLargo Launches PFAS Testing and Treatment System Selection Program - Sept. 2, 2021

BioLargo's Tonya Chandler to Present with Expert Panel at Sustain SoCal's Water Solutions 6 Web Conference on August 26, 2021 - Aug. 25, 2021

BioLargo Second Quarterly Report of 2021 Highlights Progress of PFAS Treatment Business and Expanding Engineering Client Base - Aug. 17, 2021

BIOLARGO, INC. Just Filed Its Quarterly Report: Earnings (Loss) Per ... - Aug. 16, 2021

CORRECTION: BioLargo Q2 2021 Earnings Results Webcast and Conference Call Tuesday, August 17, 2021 - 11:00 AM Eastern Time - Aug. 11, 2021

BioLargo to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 - Aug. 9, 2021

BIOLARGO, INC. director was just granted 110,294 options - July 6, 2021

BIOLARGO, INC. director was just granted 110,294 options - July 6, 2021

BIOLARGO, INC. director was just granted 88,235 options - July 6, 2021

BIOLARGO, INC. director was just granted 88,235 options - July 6, 2021

Submission of Matters to a Vote of Security Holders - June 17, 2021

Regulation FD - June 15, 2021

BioLargo 2021 Annual Meeting of Stockholders Tuesday, June 15, 2021, 10:00 AM Pacific Time - June 7, 2021

BioLargo (BLGO) to Present at LD Micro Invitational XI - June 4, 2021

BIOLARGO, INC.'s Secretary was just granted 50,000 options - May 24, 2021

BIOLARGO, INC.'s Chief Financial Officer was just granted 332,500 options - May 24, 2021

Statement of changes in beneficial ownership of securities - May 24, 2021

Current report, items 8.01 and 9.01 - May 19, 2021

BioLargo Q1 2021 Quarterly Report Highlights Improving Balance Sheet and Status of PFAS Commercial Pilots in Emerging Multi-Billion Dollar Market - May 17, 2021

BIOLARGO, INC. Just Filed Its Quarterly Report: Earnings (Loss) Per ... - May 17, 2021

Other definitive proxy statements - April 22, 2021

BIOLARGO, INC. director just picked up 563,035 shares - April 21, 2021

BIOLARGO, INC. just filed a prospectus, suggesting it plans to soon issue some securities - April 13, 2021

BIOLARGO, INC. just filed a prospectus, suggesting it plans to soon issue some securities - April 12, 2021

Prospectus [Rule 424(b)(4)] - April 12, 2021

Prospectus [Rule 424(b)(4)] - April 12, 2021

Notice of Effectiveness - April 8, 2021

Notice of Effectiveness - April 8, 2021

Notice of Effectiveness - April 8, 2021

Notice of Effectiveness - April 8, 2021

Post-Effective amendments for registration statement - April 8, 2021

Post-Effective amendments for registration statement - April 7, 2021

Post-Effective amendments for registration statement - April 7, 2021

Post-Effective amendments for registration statement - April 7, 2021

BIOLARGO, INC. director was just granted 82,418 options - April 5, 2021

BIOLARGO, INC.'s President just picked up 61,758 shares - April 5, 2021

BIOLARGO, INC. director was just granted 65,934 options - April 5, 2021

Major owner of BIOLARGO, INC. just picked up 75,606 shares - April 5, 2021

BIOLARGO, INC. director was just granted 65,934 options - April 5, 2021

BIOLARGO, INC. director was just granted 82,418 options - April 5, 2021

Other preliminary proxy statements - April 2, 2021

BIOLARGO: 00 Pm Eastern Time - March 31, 2021

Major owner of BIOLARGO, INC. just picked up 335,840 shares - March 31, 2021

BioLargo Year End 2020 Earnings Results Webcast and Conference Call Wednesday, March 31, 2021 - 5:00 PM Eastern Time - March 30, 2021

Financial Statements and Exhibits - March 19, 2021

Financial Statements and Exhibits - March 5, 2021

BioLargo Invited to Present at Isle Utilities Industrial Water Treatment Virtual Event - March 3, 2021

BioLargo's ONM Environmental Acquires EcoMist Trash Receptacle Spray Technology - Feb. 8, 2021

BioLargo and Garratt-Callahan Team Up for Product Development Project - Feb. 2, 2021

BioLargo's AEC Removal of Forever Chemicals PFAS is Confirmed 99.995% Effective in Lab Analysis Performed at the University of Tennessee - Jan. 26, 2021

BIOLARGO: Record Revenue In 2020 - Jan. 25, 2021

BIOLARGO, INC.'s Chief Financial Officer was just granted 7,500 options - Jan. 5, 2021

BIOLARGO, INC. director was just granted 156,250 options - Jan. 4, 2021

BIOLARGO, INC. director was just granted 125,000 options - Jan. 4, 2021

BIOLARGO, INC.'s President just picked up 91,260 shares - Jan. 4, 2021

BIOLARGO, INC. director was just granted 156,250 options - Jan. 4, 2021

BIOLARGO, INC. director was just granted 125,000 options - Jan. 4, 2021

BioLargo Announces Funding for Design/Installation of Full-Scale "Zero Liquid Discharge" Wastewater Treatment and Reuse Project - Dec. 22, 2020

BioLargo to Report Record Revenues in Fourth Quarter of 2020 - Dec. 21, 2020

BioLargo to Sponsor Nightingale 2030 Resilience Fund Special Online Theatrical Event: "What Would Flo Do?" - Dec. 21, 2020

President And Ceo, Biolargo, Inc - Dec. 21, 2020

BioLargo to Present at the 13th Annual LD Micro Main Event Conference - Dec. 9, 2020

Sorry, no schedule available for this company

BioLargo to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021 - Sept. 8, 2021

BioLargo Launches PFAS Testing and Treatment System Selection Program - Sept. 2, 2021

BioLargo's Tonya Chandler to Present with Expert Panel at Sustain SoCal's Water Solutions 6 Web Conference on August 26, 2021 - Aug. 25, 2021

BioLargo Second Quarterly Report of 2021 Highlights Progress of PFAS Treatment Business and Expanding Engineering Client Base - Aug. 17, 2021

CORRECTION: BioLargo Q2 2021 Earnings Results Webcast and Conference Call Tuesday, August 17, 2021 - 11:00 AM Eastern Time - Aug. 11, 2021

BioLargo Q2 2021 Earnings Results Webcast and Conference Call Wednesday, August 17, 2021 - 11:00 AM Eastern Time - Aug. 10, 2021

BioLargo to Present at the SNN Network Summer Virtual Event on Wednesday, August 18, 2021 - Aug. 9, 2021

BioLargo Discusses PFAS Commercialization, Garratt-Callahan Partnership, and $1.2 Million in New Engineering Contracts with The Stock Day Podcast - July 27, 2021

As House Passes PFAS Action Act, BioLargo Takes Next Step in Commercializing Its PFAS Treatment System - July 26, 2021

BioLargo's Engineering Subsidiary on a Hot Streak with New Contract Awards - June 29, 2021

Peer-Reviewed Scientific Paper Confirms Safety of Water Treated by BioLargo's Advanced Oxidation System - June 21, 2021

BioLargo 2021 Annual Meeting of Stockholders Tuesday, June 15, 2021, 10:00 AM Pacific Time - June 7, 2021

BioLargo (BLGO) to Present at LD Micro Invitational XI - June 4, 2021

BioLargo (BLGO) Discusses Elimination of Convertible Debt and Progress on Commercialization of PFAS Treatment Technology with The Stock Day Podcast - May 27, 2021

BioLargo Strengthens its Balance Sheet by Eliminating Convertible Debt to Position Company for Growth - May 24, 2021

Yunhong International and Giga Energy Inc. Announce Execution of Definitive Share Exchange Agreement With a Potential Value Up to Approximately $7.354 Billion - May 17, 2021

ALFI Expands Roll-out of AI-Enabled Tablets with Rideshares in Miami - May 17, 2021

BioLargo Q1 2021 Quarterly Report Highlights Improving Balance Sheet and Status of PFAS Commercial Pilots in Emerging Multi-Billion Dollar Market - May 17, 2021

BioLargo (BLGO) Q1 2021 Earnings Webcast and Conference Call Wednesday, May 19, 2021 - 4:30 PM Eastern Time - May 12, 2021

BioLargo to Present at The Benzinga Global Small Cap Conference on Friday May 14th - May 10, 2021

 


Feedback